Scalable Skin Cancer Detection for Health Systems
DermaSensor enables health systems to expand skin cancer detection across primary care sites with an objective assessment that supports appropriate triage and efficient referral pathways.
Seamless Clinical Workflow Integration
DermaSensor is a handheld, non-invasive device designed for skin cancer risk assessment and offering immediate results with minimal disruption to existing workflows.
-
Clinically-Proven Results
Real-time objective skin cancer risk detection results that aid in timely and informed clinical decision-making.
-
Ease of Operability
Using the DermaSensor is simple, with convenient virtual clinical education, workflow integration support and on-demand resources.
-
Non-Invasive Skin Cancer Detection
Each assessment includes five spectral recordings that scans beneath the surface of the skin to generate an immediate skin cancer risk result at the point of care.
Expanding Patient Access
-
Enabling Proactive Care
Primary care clinicians can evaluate suspicious lesions during routine visits, helping patients receive timely skin cancer risk assessment without waiting weeks for specialty appointments.
-
Prioritized Referrals
Objective lesion data helps clinicians prioritize dermatology referrals for higher-risk lesions, allowing specialists to focus on patients needing urgent evaluation.
-
Expanded Local Access
Patients in communities with limited dermatology availability can receive an in-office assessment from their primary care provider, lowering the overall burden of the patient care journey.
-
Improved Patient Convenience
Patients receive immediate assessment of skin lesions during the visit, reducing uncertainty and avoiding unnecessary delays in care.
The DermaSensor device enables immediate suspicious skin lesion evaluation within primary care visits, expands patient access to skin cancer risk assessment, and supports timely referrals and convenient care.
Increase Your Visibility Through Physician Finder
Health systems using DermaSensor can unlock new patient opportunities through Physician Finder, a platform that connects patients with providers offering in-office skin cancer assessments. With increased visibility, your organization can attract new patients seeking proactive skin health services, differentiate your care offerings, and connect communities with convenient access to skin cancer evaluation.
FAQs About Health Systems
How can DermaSensor support health systems and large practices?
The DermaSensor device is designed to expand skin cancer assessments within primary care settings by enabling earlier evaluation of suspicious lesions while supporting more efficient and less costly referral pathways across the health system.
How does DermaSensor support clinical decision-making?
The device provides clinically validated and objective skin cancer risk scores to support clinicians’ confidence in lesion evaluation and referral decisions.
What clinical benefits does DermaSensor provide?
In clinical studies, use of the device improved physicians’ sensitivity for detecting skin cancer and reduced missed skin cancer referrals by more than 50% compared with standard evaluation alone.
Is the device easy to implement across multiple locations?
Yes, the DermaSensor device is designed for point-of-care use and can be deployed across multiple clinics with minimal disruption to clinical workflows.
What training resources are available?
DermaSensor customers receive free access to e-learning courses designed to educate clinicians and staff on how to use and integrate the device in everyday practice.
Is reimbursement support available for DermaSensor customers?
Yes. Through our partnership with The Reimbursement Group (TRG), DermaSensor customers receive no-cost guidance on payer requirements, documentation preparation, and coding support.
How does DermaSensor mitigate operational challenges across primary care settings?
The portable DermaSensor device delivers immediate, objective skin cancer risk results in real-time, supporting clinical confidence and improving workflow efficiency.
How does DermaSensor expand patient access?
By supporting lesion evaluation in primary care, DermaSensor helps clinicians triage suspicious lesions sooner, improving patient care, particularly in areas with limited dermatology access, and supporting more timely dermatology referrals when needed.
What types of patient populations serve to benefit most?
Practices with larger patient panels or populations at higher risk for skin cancer may benefit most, as frequent encounters with suspicious lesions create opportunities for timely, in-office assessment.
80-0009.12
